Standout Papers
Citation Impact
Citing Papers
Brain monoglyceride lipase participating in endocannabinoid inactivation
2002
Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus
2020 StandoutNobel
Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance
2014 StandoutNobel
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
2007 StandoutScience
Salt Intake Augments Hypotensive Effects of Transient Receptor Potential Vanilloid 4
2008
The endocannabinoid nervous system
2001
Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides.
2002
Pharmacology of Cannabinoid CB 1 and CB 2 Receptors
1997
Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway
2002
Arresting a Transient Receptor Potential (TRP) Channel
2010 StandoutNobel
The aryl hydrocarbon receptor and light
2006
The endocannabinoid system as a target for therapeutic drugs
2000
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
2006
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
1998
Actions of Cannabinoids on Membrane Properties and Synaptic Transmission in Rat Periaqueductal Gray Neurons In Vitro
2000
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
2001
Cannabinoid Transmission and Pain Perception
1998
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
2006 Standout
The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling
1995
The general anesthetic propofol increases brain N‐arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase
2003
Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling
2004
SR 141716A Acts as an Inverse Agonist to Increase Neuronal Voltage-Dependent Ca2+ Currents by Reversal of Tonic CB1 Cannabinoid Receptor Activity
1998
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
2005
Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice
2004
Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor-1
2004
Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulators
1999
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Recent advances in understanding the mechanisms of TCDD immunotoxicity
2002
The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy
2003
Cannabinoid CB1‐receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
2001
The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes
2000
Modulation of anxiety through blockade of anandamide hydrolysis
2002 Standout
Cannabinoid physiology and pharmacology: 30 years of progress
2004
Simultaneous Measurement of Anandamide and 2-Arachidonoylglycerol by Polymyxin B-Selective Adsorption and Subsequent High-Performance Liquid Chromatography Analysis: Increase in Endogenous Cannabinoids in the Sera of Patients with Endotoxic Shock
2001
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol
2002
Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell
2005
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
2008 StandoutNature
Massive accumulation of N‐acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?
2004
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
1998
The role of Cannabinoids in neurodegenerative diseases
2001
The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940
1996
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2
2007
A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1
1997
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)
1999
Pharmacological Actions of Cannabinoids
2005
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain
2004
Activation and Binding of Peroxisome Proliferator-Activated Receptor γ by Synthetic Cannabinoid Ajulemic Acid
2003
Structural Requirements for Cannabinoid Receptor Probes
2005
Cannabinoid Receptor Expression in Immune Cells
1996
Structure—Activity Relationships Among N‐Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide Transporter
2000
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27
2010
Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors
2004
Cannabinoid analgesia
2002
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
2003
Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors
1999
Role of cannabinoid CB1 receptors and tumor necrosis factor‐α in the gut and systemic anti‐inflammatory activity of SR 141716 (Rimonabant) in rodents
2003
Antagonism of LPS and IFN-γ Induction of iNOS in Human Saphenous Vein Endothelium by Morphine and Anandamide by Nitric Oxide Inhibition of Adenylate Cyclase
1998
2-Arachidonoylglycerol and Anandamide Oppositely Modulate Norepinephrine Release from the Rat Heart Sympathetic Nerves
2001
Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors
1998
Generation of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, in Picrotoxinin-Administered Rat Brain
2000
Expression of Cannabinoid Receptor mRNA in Murine and Human Leukocytes
1995
Emerging properties of cannabinoid medicines in management of multiple sclerosis
2005
New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia
2004
Control of pain initiation by endogenous cannabinoids
1998 StandoutNature
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
2003
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Cannabinoids and brain injury: therapeutic implications
2002
Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis
2001
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
2005
Cardiovascular Pharmacology of Cannabinoids
2005
Endocannabinoids as physiological regulators of colonic propulsion in mice
2002
Effect of cannabinoids on neural transmission in rat gastric fundus
2002
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-α production in murine macrophages, and in mice
2000
Endocannabinoids
1998
Endocannabinoids Modulate N-Type Calcium Channels and G-Protein-Coupled Inwardly Rectifying Potassium Channels via CB1 Cannabinoid Receptors Heterologously Expressed in Mammalian Neurons
2004
Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2
2003
Localization of Diacylglycerol Lipase-α around Postsynaptic Spine Suggests Close Proximity between Production Site of an Endocannabinoid, 2-Arachidonoyl-glycerol, and Presynaptic Cannabinoid CB1 Receptor
2006
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat
1997
Cannabinoid signaling in glial cells
2004
Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?
2002
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart
2003
Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N-Docosahexaenoylethanolamine in Bovine Retina
1999
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
2003
Identification of the CB1 Cannabinoid Receptor and Fatty Acid Amide Hydrolase (FAAH) in the Human Placenta
2003
Mucins, Mucus, and Sputum
2009
Differential expression of cannabinoid CB2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation
2001
ETHANOL INDUCES HIGHER BEC IN CB1 CANNABINOID RECEPTOR KNOCKOUT MICE WHILE DECREASING ETHANOL PREFERENCE
2004
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
1999 StandoutNatureNobel
Suppression of experimetal autoimmune encephalomyelitis by cannabinoids
1994
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
1996 StandoutNature
Molecular Neurobiology of The Cannabinoid Receptor
1996
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Coronary Vasodilator Effects of Endogenous Cannabinoids in Vasopressin-Preconstricted Unpaced Rat Isolated Hearts
2005
The gastrointestinal pharmacology of cannabinoids
2001
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
2003
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
2003
Blood pressure regulation by endocannabinoids and their receptors
2005
Discovery and characterization of endogenous cannabinoids
1999
Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea‐pig myenteric plexus
1997
Endocannabinoids in the immune system and cancer
2002
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
2005
Regulation and role of transforming growth factor-β in immune tolerance induction and inflammation
2004
The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
2001
Cannabinoid-based drugs as anti-inflammatory therapeutics
2005
A historical overview of chemical research on cannabinoids
2000
Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms
2001
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
1998
Review article: endocannabinoids and their receptors in the enteric nervous system
2005
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
1999
Inhibition by 2-Arachidonoylglycerol, a Novel Type of Possible Neuromodulator, of the Depolarization-Induced Increase in Intracellular Free Calcium in Neuroblastoma × Glioma Hybrid NG108-15 Cells
1997
Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors
2006
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
2007 StandoutNature
Molecular biology of cannabinoid receptors
2002
Biochemistry and pharmacology of endovanilloids
2007
Aberrant cannabinoid signaling impairs oviductal transport of embryos
2004
Receptor-dependent formation of endogenous cannabinoids in cortical neurons
2001
The endocannabinoid system and its therapeutic exploitation
2004
Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor
2002
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake
2003
Comparison of novel cannabinoid partial agonists and SR141716A in the guinea‐pig small intestine
2000
Endocannabinoids as cardiovascular modulators
2000
Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2′-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide
2005
Novel selective and metabolically stable inhibitors of anandamide cellular uptake
2003
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis
2005
Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1receptors on peripheral sympathetic nerves
1996
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
2007
Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor‐dependent G‐protein activation in rat cerebellar membranes
2001
Cannabinoid Receptor Signaling
2005
Effects of cannabinoid receptor‐2 activation on accelerated gastrointestinal transit in lipopolysaccharide‐treated rats
2004
Delta-9-tetrahydrocannabinol suppresses tumor necrosis factor α maturation and secretion but not its transcription in mouse macrophages
1996
Gut microbiome and health: mechanistic insights
2022 Standout
Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated hearts
2002
The endocannabinoid-CB1 receptor system in pre- and postnatal life
2004
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells
1995
The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs
2005
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock‐out mice
2004
In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors
2000
Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor
1999
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
2002
Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system
1998
Transforming growth factor-β induces development of the TH17 lineage
2006 StandoutNature
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
A second endogenous cannabinoid that modulates long-term potentiation
1997 Nature
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
Endogenous Cannabinoids Mediate Retrograde Signals from Depolarized Postsynaptic Neurons to Presynaptic Terminals
2001
Involvement of the cAMP/protein kinase A pathway and of mitogen‐activated protein kinase in the anti‐proliferative effects of anandamide in human breast cancer cells
1999
Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration
2001
An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing
1995
The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells
2006
Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase
2000
Targeting cannabinoid receptors to treat leukemia: Role of cross-talk between extrinsic and intrinsic pathways in Δ9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells
2005
TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia
2005
Cellular signal transduction by anandamide and 2-arachidonoylglycerol
2000
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide
2002
Presynaptic Inhibition Caused by Retrograde Signal from Metabotropic Glutamate to Cannabinoid Receptors
2001
Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor
2000
Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase
2005
Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial Muscle
2003
Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations
1995
Identification of the CB1 Cannabinoid Receptor and Fatty Acid Amide Hydrolase (FAAH) in the Human Placenta
2003
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
2000
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation
2002
Cannabinoid Receptors and Their Relationships with Neuropsychiatric Disorders
2005
Ether‐linked analogue of 2‐arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species
2003
Cannabinoid receptors and pain
2001
2-Arachidonoylglycerol Increases in Ischemia–Reperfusion Injury of the Rat Liver
2005
Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity
1998
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
2000
Relationships Between Ligand Affinities for the Cerebellar Cannabinoid Receptor CB1 and the Induction of GDP/GTP Exchange
1999
Presynaptic Modulation by Endocannabinoids
2007
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide
2000
p38 MAPK is involved in CB2 receptor‐induced apoptosis of human leukaemia cells
2005
The endogenous cannabinoid system and the basal ganglia
2002
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats
2003
Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors
1999
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesias
2003
Effects of cannabinoids on energy metabolism
1999
Cannabinoids: potential anticancer agents
2003
Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice
2000
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
1998
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
2002
Synergistic efects of opioid and cannabinoid antagonists on food intake
2001
Detection of an Endogenous Cannabimimetic Molecule, 2-Arachidonoylglycerol, and Cannabinoid CB1 Receptor mRNA in Human Vascular Cells: Is 2-Arachidonoylglycerol a Possible Vasomodulator?
1998
The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions
2001
Cannabinoid receptor systems: therapeutic targets for tumour intervention
2003
Promoter analysis of TCDD-inducible genes in a thymic epithelial cell line indicates the potential for cell-specific transcription factor crosstalk in the AhR response
2008
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
2004
Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB2 receptor
2000
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a “CB3” receptor
2003
Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation
1999
Rapid Glucocorticoid-Mediated Endocannabinoid Release and Opposing Regulation of Glutamate and γ-Aminobutyric Acid Inputs to Hypothalamic Magnocellular Neurons
2005
Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage
2000
Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea‐pig ileum
2000
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
1996
Cannabinoids: a real prospect for pain relief
2002
Structural snapshots of TRPV1 reveal mechanism of polymodal functionality
2021 StandoutNobel
Fatty-Acid Amide Hydrolase Is Expressed in the Mouse Uterus and Embryo during the Periimplantation Period1
1999
Hypothesis: cannabinoid therapy for the treatment of gliomas?
2004
Pharmacology of cannabinoid CB1 and CB2 receptors
1997
TGFβ in Cancer
2008 Standout
Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1
2004
The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons
1998
Cannabinoids in Multiple Sclerosis
2004
Cannabinoid receptors and the regulation of immune response
2000
Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE‐1 isoform via Gi‐mediated mitogen activated protein kinase signaling transduction pathways
1999
Transacylase‐Mediated and Phosphodiesterase‐Mediated Synthesis ofN‐Arachidonoylethanolamine, an Endogenous Cannabinoid‐Receptor Ligand, in Rat Brain Microsomes
1996
CB2 cannabinoid receptor mediation of antinociception
2006
Δ9-Tetrahydrocannabinol-Induced Apoptosis in the Thymus and Spleen as a Mechanism of Immunosuppression in Vitro and in Vivo
2002
Ceramide: a new second messenger of cannabinoid action
2001
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
1998
Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1
2002
The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
2005
An endocannabinoid mechanism for stress-induced analgesia
2005 Nature
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Tetrahydrocannabinol inhibition of macrophage nitric oxide production
1996
Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide
2001
The molecular logic of endocannabinoid signalling
2003 Standout
The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway
2006
Cannabinoid CB1 receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat
2002
Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes
1997
Cannabinoids in the treatment of glaucoma
2002
Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice
2006
Changes in Rat Spleen Cannabinoid Receptors after Chronic CP-55,940: An Autoradiographic Study
1997
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice
2003
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
2006
Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-α production by human mononuclear cells
2002
Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells
1995
Evaluation of CB1 Receptor Knockout Mice in the Morris Water Maze
2002
Marijuana, Receptors and Immunomodulation
1995
Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice
1998
Role of the endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson’s disease and schizophrenia
2001
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
2004
Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes
2000
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
2006 StandoutNature
Effects of topical anandamides on intraocular pressure in normotensive rabbits
1996
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Anandamide: some like it hot
2001
De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis
2002
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
2001 Nature
CB2 cannabinoid receptor-mediated peripheral antinociception
2001
Endocannabinoids and related fatty acid derivatives in pain modulation
2002
The cell surface mucin MUC1 limits the severity of influenza A virus infection
2017
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1
2004 StandoutNatureNobel
Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus
2002
Signaling Pathway Associated with Stimulation of CB2 Peripheral Cannabinoid Receptor
1996
Further evidence for the presence of cannabinoid CB1 receptors in guinea‐pig small intestine
1996
Ah receptor and NF-κB interactions: mechanisms and physiological implications
2002
Endocannabinoid-Mediated Control of Synaptic Transmission
2009
Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes
2004
Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview
2002
Role of endocannabinoid system in mental diseases
2004
Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
2002
Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
2017
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
The effects of cannabinoids on the brain
1999
The endocannabinoid signalling system: Biochemical aspects
2005
Lectin Domains of Polypeptide GalNAc Transferases Exhibit Glycopeptide Binding Specificity
2011 StandoutNobel
Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies
1998
Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development
2000
(—)-Δ9-Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase
1996
Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma
1998
Endocannabinoids and liver disease – review
2005
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
2008 StandoutNature
Endocannabinoids in the regulation of appetite and body weight
2005
Cannabinoids and cell fate
2002
The CB1 Cannabinoid Receptor of Astrocytes Is Coupled to Sphingomyelin Hydrolysis through the Adaptor Protein Fan
2001
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
2006
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
2014 StandoutNobel
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
2004
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
2001
Identification and characterisation of a novel splice variant of the human CB1 receptor
2004
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
2005
The fatty acid amide hydrolase (FAAH)
2000
Striatal Cannabinoid CB1 Receptor mRNA Expression Is Decreased in the Reserpine-Treated Rat Model of Parkinson's Disease
2001
Evidence for novel cannabinoid receptors
2005
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
1994 StandoutNature
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection
2002
A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut Inflammation
2004
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts
2002
Endocannabinoids and the gut
2002
Central and peripheral components of the pressor effect of anandamide in urethane‐anaesthetized rats
2005
Marijuana, immunity and infection
1998
Determination of the cannabinoid receptors in mouse × rat hybridoma NG108-15 cells and rat GH4C 1 cells
1996
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase
1998
Cannabis, cannabinoids and reproduction
2003
Pathogen Recognition and Innate Immunity
2006 Standout
Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand
1998
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1
2000
Neuropharmacology and therapeutic potential of cannabinoids
2000
Cannabinoids and neuroinflammation
2004
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
2006 StandoutNature
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
2005
The quest for a vascular endothelial cannabinoid receptor
2002
Therapeutic Potential of Cannabinoids in CNS Disease
2003
Endocannabinoid control of food intake and energy balance
2005
The endocannabinoid system links gut microbiota to adipogenesis
2010
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
2002
The endocannabinoid system drives neural progenitor proliferation
2005
Cannabinoid Inhibition of the Processing of Intact Lysozyme by Macrophages: Evidence for CB2 Receptor Participation
1999
CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS
1998
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
2002
Toxic Potential of Materials at the Nanolevel
2006 StandoutScience
Cannabis: pharmacology and toxicology in animals and humans
1996
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
2003
The Cannabinoid System and Cytokine Network
2000
Endogenous cannabinoids and appetite.
2001
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
2005
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
2000
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction
2003
Therapeutic potential of cannabinoid receptor agonists as analgesic agents
2005
Distinct Effects of TGF-β1 on CD4+ and CD8+ T Cell Survival, Division, and IL-2 Production: A Role for T Cell Intrinsic Smad3
2005
The neurobiology and evolution of cannabinoid signalling
2001
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
1999 StandoutScience
In Vitro and in Vivo Pharmacological Characterization of JTE-907, a Novel Selective Ligand for Cannabinoid CB2 Receptor
2001
Dendritic cells with TGF-β1 differentiate naïve CD4+CD25−T cells into islet-protective Foxp3+regulatory T cells
2007 StandoutNobel
Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide
1998
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
1995
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
1994 Standout
Cannabinoid Suppression of Noxious Heat-Evoked Activity in Wide Dynamic Range Neurons in the Lumbar Dorsal Horn of the Rat
1999
Δ-9-Tetrahydrocannabinol Enhances Breast Cancer Growth and Metastasis by Suppression of the Antitumor Immune Response
2005
Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses
2002
The CB1 Cannabinoid Receptor of Astrocytes Is Coupled to Sphingomyelin Hydrolysis through the Adaptor Protein Fan
2001
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172
2004
N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo
2000
Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease
2005 StandoutNobel
Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
1998
The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells
1999
Role of Endogenous Cannabinoids in Synaptic Signaling
2003
The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
1995
Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit
2011 StandoutScience
Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors
1999
Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain
2006
Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies
2005
Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation1
2000
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
2007
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
2001
Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase
2003
Localization of cannabinoid CB1 receptors in the human anterior eye and retina.
1999
Modulation and Functional Involvement of CB2 Peripheral Cannabinoid Receptors During B-Cell Differentiation
1998
Molecular and Immune Mechanisms in the Pathogenesis of Cardiomyopathy
1997
Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor
2000
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
1993
Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension
1998
Substrate Specificity and Stereoselectivity of Rat Brain Microsomal Anandamide Amidohydrolase
1999
Inhibitory effects of cannabinoid CB 1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis
2003
Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis
2003
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition
2005
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
1998
Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide
2000
Inhibition of tumor angiogenesis by cannabinoids
2003
Functional CB1 cannabinoid receptors in human vascular endothelial cells
2000
Cannabinoid receptor agonists and antagonists
1998
Emerging Challenges in Regulatory T Cell Function and Biology
2007 StandoutScienceNobel
Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-Administration
2001
Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
1997
Cannabinoid ligand-receptor signaling in the mouse uterus.
1995
Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological Function
1999
Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens
2003
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
1999
Cannabinoid‐receptor expression in human leukocytes
1993
Cannabinoids and the gastrointestinal tract
2001
Endocannabinoids and Neuroprotection
2002
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
The Cannabinoid 1 Receptor Antagonist, AM251, Prolongs the Survival of Rats with Severe Acute Pancreatitis
2005
Δ9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-γ, IL-12, and IL-12 Receptor β2 Responses toLegionella pneumophilaInfection
2000
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
2001
Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo.
2001
CB 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
2005
Pharmacology of cannabinoids.
2004
The cannabinoid system and immune modulation
2003
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
2004
Activation of CB 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
2003
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
2005
SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist
1999
Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling
2002
Cannabinoids Protect Cells from Oxidative Cell Death: A Receptor-Independent Mechanism
2000
Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing
2005
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
2006
Dysregulated Cannabinoid Signaling Disrupts Uterine Receptivity for Embryo Implantation
2001
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
2005
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
2002
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
2003
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
2001
A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis
2000
N-arachidonoyll -serine, an endocannabinoid-like brain constituent with vasodilatory properties
2006
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
2003
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
2001 StandoutScienceNobel
Endogenous cannabinoids and appetite
2001
Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells
1997
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1receptor coupling to Gq/11G proteins
2005
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
2004
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
2001
2-Arachidonoylglycerol
2004
Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain.
2006
Up‐regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation
2006
Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway
2000
Involvement of Cannabinoid Receptors in the Intraocular Pressure-Lowering Effects of WIN55212-2
2000
A biosynthetic pathway for anandamide
2006
Structural determinants for recognition and translocation by the anandamide transporter
1999
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
2004
Mutation of a Highly Conserved Aspartate Residue in the Second Transmembrane Domain of the Cannabinoid Receptors, CB1 and CB2, Disrupts G-Protein Coupling
1998
Works of Norbert E. Kaminski being referenced
Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.
1995
Putative Link between Transcriptional Regulation of IgM Expression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and the Aryl Hydrocarbon Receptor/Dioxin-Responsive Enhancer Signaling Pathway
2000
Cannabinol-Mediated Inhibition of Nuclear Factor-κB, cAMP Response Element-Binding Protein, and Interleukin-2 Secretion by Activated Thymocytes
1999
Cannabinoids inhibit the activation of ERK MAPK in PMA/Io-stimulated mouse splenocytes
2003
Cyclic AMP Is an Essential Factor in Immune Responses
1995
Identification of functional aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator in murine splenocytes
1996
Modulation of Airway Responses to Influenza A/PR/8/34 by Δ9-Tetrahydrocannabinol in C57BL/6 Mice
2007
Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice ☆
2003
Δ9-tetrahydrocannabinol selectivity inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function
1993
Inhibition of the Cyclic AMP Signaling Cascade and Nuclear Factor Binding to CRE and κB Elements by Cannabinol, a Minimally CNS-Active Cannabinoid
1998
Involvement of Blimp-1 and AP-1 Dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin–mediated Suppression of the IgM Response by B Cells
2009
Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors
1998
Cannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship
2006
Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2
1996
Molecular Mechanisms of Toxicant-Induced Immunosuppression: Role of Second Messengers
1996
Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by Δ9-tetrahydrocannabinol (Δ9-THC)
1997
Inhibition of adenylate cyclase by Δ9-Tetrahydrocannabinol in mouse spleen cells: A potential mechanism for cannabinoid- mediated immunosuppression
1992
Endocannabinoid Regulates Blood Pressure via Activation of the Transient Receptor Potential Vanilloid Type 1 in Wistar Rats Fed a High-Salt Diet
2007
Transient CRE- and κB site-binding is cross-regulated by cAMP-dependent protein kinase and a protein phosphatase in mouse splenocytes
1997
Suppression of Interleukin-2 by the Putative Endogenous Cannabinoid 2-Arachidonyl-Glycerol Is Mediated through Down-regulation of the Nuclear Factor of Activated T Cells
1998
A Cyclooxygenase Metabolite of Anandamide Causes Inhibition of Interleukin-2 Secretion in Murine Splenocytes
2004
Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line
2003
Interactions at a dioxin responsive element (DRE) and an overlapping κB site within the hs4 domain of the 3′α immunoglobulin heavy chain enhancer
2004
Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism
1994
TGF-β1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3ε mAb- and CD28 mAb-activated splenocytes and thymocytes
2000
Examination of the immunosuppressive effect of Δ9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes
2001
Aryl Hydrocarbon Receptor-Dependent Inhibition of AP-1 Activity by 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Activated B Cells
2002
Evidence for a Cannabinoid Receptor in Immunomodulation by Cannabinoid Compounds
1993
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
1995 Standout
Cannabinol Enhancement of Interleukin-2 (IL-2) Expression by T Cells Is Associated with an Increase in IL-2 Distal Nuclear Factor of Activated T Cell Activity
2002
Cannabinoid Receptors CB1 and CB2: A Characterization of Expression and Adenylate Cyclase Modulation within the Immune System
1997
Inhibition of the cAMP signaling cascade via cannabinoid receptors: a putative mechanism of immune modulation by cannabinoid compounds
1998
Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression
1996
Evidence for Cannabinoid Receptor-Dependent and -Independent Mechanisms of Action in Leukocytes
2003
Leukocyte Activation Induces Aryl Hydrocarbon Receptor Up-Regulation, DNA Binding, and Increased Cyp1a1Expression in the Absence of Exogenous Ligand
1997
Transforming Growth Factor-Beta 1 (TGF-β1) Promotes IL-2 mRNA Expression Through the Up-regulation of NF-κB, AP-1 and NF-AT in EL4 Cells
1998
Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
1992
Aryl Hydrocarbon Receptor-Dependent Suppression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of IgM Secretion in Activated B Cells
1998
Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol
2001
Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
1996
Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes.
1999
Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.
1998
VR1-Mediated Depressor Effects During High-Salt Intake
2005
AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun
2000
Lipopolysaccharide Activation of Murine Splenocytes and Splenic B Cells Increased the Expression of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Nuclear Translocator
1998
Time-Dependent Airway Epithelial and Inflammatory Cell Responses Induced by Influenza Virus A/PR/8/34 in C57BL/6 Mice
2007
Smad3 Is Essential for TGF-β1 to Suppress IL-2 Production and TCR-Induced Proliferation, but Not IL-2-Induced Proliferation
2004
Anandamide-Induced Depressor Effect in Spontaneously Hypertensive Rats
2003